|
MechanismAMPA receptor modulators |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date01 Jan 1977 |
|
Mechanism50S subunit inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date01 Jan 1977 |
|
Mechanism50S subunit inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Japan |
First Approval Date13 Oct 1955 |
苯胺洛芬注射液在中国老年研究参与者中单次给药的药代动力学和安全性研究
[Translation] Pharmacokinetics and safety of single-dose anilinoprofen injection in elderly Chinese study participants
主要目的
评价苯胺洛芬注射液在老年研究参与者中单次给药的药代动力学特征。
次要目的
评价苯胺洛芬注射液在老年研究参与者中单次给药的安全性。
[Translation] Primary objective
To evaluate the pharmacokinetic characteristics of a single dose of fenprofen injection in elderly study participants.
Secondary objective
To evaluate the safety of a single dose of fenprofen injection in elderly study participants.
苯胺洛芬注射液在轻度、中度肝功能不全受试者和健康受试者中的非随机、开放、平行对照的药代动力学和安全性研究
[Translation] A non-randomized, open-label, parallel-controlled pharmacokinetic and safety study of anilinoprofen injection in subjects with mild and moderate hepatic impairment and healthy subjects
主要目的:评价苯胺洛芬注射液在轻度、中度肝功能不全受试者与匹配的健康受试者中的药代动力学特征差异,为肝功能不全患者的合理临床用药提供科学依据。
次要目的:评价轻度、中度肝功能不全受试者和健康受试者使用苯胺洛芬注射液的安全性。
[Translation] Primary objective: To evaluate the differences in the pharmacokinetic characteristics of fenprofen injection in subjects with mild and moderate hepatic impairment and matched healthy subjects, and to provide a scientific basis for the rational clinical use of drugs in patients with hepatic impairment.
Secondary objective: To evaluate the safety of fenprofen injection in subjects with mild and moderate hepatic impairment and healthy subjects.
苯胺洛芬注射液在轻度、中度肾功能不全受试者和健康受试者中非随机、开放、平行对照的药代动力学和安全性研究
[Translation] A non-randomized, open-label, parallel-controlled pharmacokinetic and safety study of anilinoprofen injection in subjects with mild and moderate renal impairment and healthy subjects
主要目的:评价苯胺洛芬注射液在轻度、中度肾功能不全及健康受试者中的药代动力学特征。
次要目的:评价苯胺洛芬注射液在轻度、中度肾功能不全及健康受试者中的安全性。
[Translation] Primary objective: To evaluate the pharmacokinetic characteristics of fenprofen injection in subjects with mild and moderate renal impairment and healthy subjects.
Secondary objective: To evaluate the safety of fenprofen injection in subjects with mild and moderate renal impairment and healthy subjects.
100 Clinical Results associated with Dalian Tianyu Pharmaceutical Co.,Ltd.
0 Patents (Medical) associated with Dalian Tianyu Pharmaceutical Co.,Ltd.
100 Deals associated with Dalian Tianyu Pharmaceutical Co.,Ltd.
100 Translational Medicine associated with Dalian Tianyu Pharmaceutical Co.,Ltd.